Hhv-8 infection and post-transplant malignancies

Published: May 29, 2009
Abstract Views: 144
Untitled (): 0
PDF: 247
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Human herpesvirus 8 (HHV-8)/Kaposi sarcoma associated herpesvirus (KSHV) has been identified in 1994 from the Kaposi sarcoma (KS) tissues of patients with acquired immunodeficiency syndrome (AIDS). HHV-8 has been classified as a gamma-herpesvirus, related to Epstein-Barr virus (EBV) and herpesvirus saimiri. Like other herpesviruses, HHV-8 is a large double-stranded DNA virus that replicates in the nucleus as a closed circular episome during latency but linearizes during virion packaging and replication. HHV-8 viral genome is unique, compared with the genome of other human herpesviruses, as it contains genes associated either with the latent or the lytic phase of the viral cycle, which are homologous to cellular genes, involved in the control of cell cycle and apoptosis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Luppi, M. (2009). Hhv-8 infection and post-transplant malignancies. Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.260